International Institute of Molecular and Cell Biology
The International Institute of Molecular and Cell Biology was founded in 1999.
The main goals of IIMCB are:
- to carry out high quality research in molecular biomedicine;
- to create the best possible conditions for ambitious, motivated group leaders;
- to implement modern biotechnology;
- to teach and popularize molecular medicine and human genetics.
The research focuses on:
- biology and biochemistry of chaperones;
- modelling of the structure of restriction enzymes, methyltransferases and photoreceptor proteins;
- crystallographic structure determination of proteins;
- studies of molecular basis of neurodegenerative disease and studies of proteins
- implicated in the mechanism of learning and memory and pathogenesis of Alzheimer's disease
- interdependence between intracellular endocytic transport and nuclear signaltransduction
- biology of dendritic tree development;
- mechanics of the actomyosin cortex;
- structural and biochemical studies of nucleic acid enzymes.
The highest quality of science achieved at IIMCB enabled commercialization of promising inventions by spin-off companies like Proteon Pharmaceuticals developing technology of characterizing the immunotoxic activity of xenobiotic substances.
To further explore commercialisation opportunities IIMCB develops cooperation with industrial partners through:
- joint research projects;
- scientific services and expertise;
- sharing research equipment.
Based on these principles IIMCB has a succesfull collaboration with a number of companies, among the others: Adamed, Celon Pharma, Fermentas, Kucharczyk, Polfa.
FOLLOW US!
Watch interesting discussions and add us to your friends!
